Physician profile
Albert S Chang
NPI 1619991353
$7,453.03
in general payments reported to CMS, 2019-2025
12 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $927 · 2020: $136 · 2022: $115 · 2023: $6,019 · 2024: $145 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Food and Beverage: $275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Food and Beverage | $274.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,250.68 | 2020-2023 | Davinci Xi |
| Medical Device Business Services, INC. | $863.74 | 2019 | |
| Medtronic, INC. | $87.27 | 2024 | Signia |
| Ethicon US, LLC | $56.54 | 2019-2025 | Harmonic |
| Integra Lifesciences Corporation | $43.23 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $39.10 | 2024-2025 | Zerbaxa |
| Pulmonx Corporation | $22.44 | 2019 | |
| Atricure, INC. | $20.11 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Abbvie INC. | $19.19 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $18.70 | 2024 | Exparel, Zilretta, Iovera |
| Olympus America INC. | $18.50 | 2025 | 4k Camera Head, Visera 4k Uhd Camera Control Unit |
| Davol INC. | $13.53 | 2025 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.